Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.218064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Jiaoduan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Department of Biliary-Pancreatic Surgery, Department of Gastrointesti…. Hauptthemen laut MEDLINE: Adenocarcinoma, Duodenal Neoplasms, Tumor-Associated Macrophages, Chemokine CCL5. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Guangxi Medical University, Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Duodenal adenocarcinoma (DA) is a rare gastrointestinal malignancy associated with poor prognosis and limited therapeutic options. To define the DA tumor microenvironment (TME), we performed single-cell RNA sequencing (scRNA-seq) on primary DA tumors and matched adjacent normal tissues. This analysis revealed substantial heterogeneity among malignant epithelial cells, including a transcriptionally distinct subset characterized by the upregulation of immune-related genes, which constitutes an immune-associated transcriptional program. Notably, this program included high expression of the chemokine CCL5, which facilitated the recruitment of CCR1+ macrophages. Using patient-derived DA organoids, we identified malignant cells exhibiting immune-related transcriptional signatures, including elevated CCL5. Functional assays demonstrated that CCL5 promoted CCR1+ macrophage migration, an effect suppressed by both the CCR1 antagonist BX471 and CCL5-neutralizing antibody. In co-culture, CCL5-expressing DA organoids displayed enhanced survival and proliferation in the presence of CCR1+ macrophages, while pharmacological blockade of CCR1 significantly increased tumor cell death. Bulk transcriptomic profiling revealed that CCR1 downregulates pro-apoptotic signaling in tumor cells, thereby promoting cell survival and growth. Importantly, combining CCL5/CCR1 inhibitors with standard chemotherapeutic agents resulted in synergistic tumor cell killing. Together, our findings establish the CCL5/CCR1 axis as a key mediator of tumor-macrophage crosstalk in DA, supporting immune evasion and chemoresistance via suppression of macrophage-induced apoptosis. Targeting this axis may represent a promising therapeutic strategy to enhance the efficacy of conventional chemotherapy in DA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Department of Biliary-Pancreatic Surgery, Department of Gastrointestinal Surgery, Shanghai Key Laboratory of Cancer System Regulation and C…
- Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, PR China.
- Department of Oncology, The Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, PR China.
- Shanghai OneTar Biomedicine, Shanghai, PR China.
- Shanghai Institute of Health Sciences, Shanghai, PR China.
- Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, PR China. Electronic address: ai_na_he@yahoo.com.
Förderung
- Natural Science Foundation of Fujian Province
- Guangxi Medical University
- Shanghai Jiao Tong University School of Medicine
- Science and Technology Commission of Shanghai Municipality
- Ministry of Education of the People's Republic of China
- Xiamen University
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Zhang, L., Zheng, C., Lin, X., Cao, D., Zhao, S., Wang, S., Yu, B., Wei, G., Kong, X., Liu, X., He, A., Xiao, X., & Xiang, D. (2025). Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.218064
Vancouver
Li J, Zhang L, Zheng C, Lin X, Cao D, Zhao S, et al. Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.218064
BibTeX
@article{Li2025,
author = {Li, Jiaoduan and Zhang, Liyi and Zheng, Chen and Lin, Xiaolin and Cao, Dongyan and Zhao, Shasha and Wang, Shuang and Yu, Bin and Wei, Guiying and Kong, Xianming and Liu, Xiao and He, Aina and Xiao, Xiuying and Xiang, Dongxi},
title = {Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.218064}
}
EUVIMED